BARCLAYS PLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$81
-25.7%
25,963
+22.9%
0.00%
Q2 2023$109
-92.6%
21,123
-92.4%
0.00%
-100.0%
Q1 2023$1,473
+64.4%
279,687
-12.3%
0.00%
Q4 2022$896
-93.6%
318,834
+9659.2%
0.00%
Q3 2022$14,000
-78.8%
3,267
-80.0%
0.00%
Q2 2022$66,000
-59.0%
16,369
-49.6%
0.00%
Q1 2022$161,000
-90.8%
32,481
-87.0%
0.00%
Q4 2021$1,746,000
+130.6%
250,624
+230.9%
0.00%
Q3 2021$757,000
+227.7%
75,737
+362.7%
0.00%
Q2 2021$231,000
-78.6%
16,368
-75.1%
0.00%
-100.0%
Q1 2021$1,077,000
+132.1%
65,631
+192.6%
0.00%
Q4 2020$464,000
+100.9%
22,428
-26.3%
0.00%
Q3 2020$231,000
-6.1%
30,447
+3.0%
0.00%
Q2 2020$246,000
+251.4%
29,571
+110.8%
0.00%
Q1 2020$70,000
-58.3%
14,029
-67.0%
0.00%
Q4 2019$168,000
-1.8%
42,465
-24.4%
0.00%
Q3 2019$171,000
-41.0%
56,197
-14.5%
0.00%
Q2 2019$290,000
+218.7%
65,763
+187.5%
0.00%
Q1 2019$91,000
+3.4%
22,878
+2.9%
0.00%
Q4 2018$88,000
-72.9%
22,229
-53.0%
0.00%
Q3 2018$325,000
+100.6%
47,346
+96.5%
0.00%
Q2 2018$162,000
-12.0%
24,092
-14.8%
0.00%
Q1 2018$184,000
+922.2%
28,262
+587.0%
0.00%
Q4 2017$18,000
-65.4%
4,114
-51.7%
0.00%
Q3 2017$52,000
+642.9%
8,520
+955.8%
0.00%
Q2 2017$7,000
-97.7%
807
-97.6%
0.00%
Q1 2017$308,000
+1040.7%
33,256
+916.1%
0.00%
Q4 2016$27,000
+1250.0%
3,273
+998.3%
0.00%
Q3 2016$2,000
-90.0%
298
-92.4%
0.00%
Q2 2016$20,000
+11.1%
3,905
+92.6%
0.00%
Q1 2016$18,000
-61.7%
2,028
-61.3%
0.00%
Q4 2015$47,000
-44.7%
5,237
-13.6%
0.00%
Q3 2015$85,000
-14.1%
6,059
+28.1%
0.00%
Q2 2015$99,000
+1314.3%
4,729
+2633.5%
0.00%
Q1 2015$7,000
-88.5%
173
-93.4%
0.00%
Q4 2014$61,0002,6270.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders